Track Bausch Health Companies Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Bausch Health Companies Inc. BVF.F · Stock Open Bausch Health Companies Inc. in new tab

5.32 EUR
EPS
-2.52
P/B
-1.27
Beta
0.38
Loading chart...
Key Metrics
EPS-2.52
Book Value-4.06
Price to Book-1.27
% Insiders11.123%
Growth
Revenue Growth0.13%
Earnings Growth0.70%
Estimates
Forward P/E1.09
Forward EPS4.71

DCF Valuation

Tweak assumptions to recompute fair value for Bausch Health Companies Inc. (BVF.F)
Currency: EUR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Bausch Health Companies Inc. Logo Bausch Health Companies Inc. Analysis (BVF.F)

Canada Health Care Official Website Stock

Is Bausch Health Companies Inc. a good investment? Bausch Health Companies Inc. (BVF.F) is currently trading at 5.32 EUR.

Investor FAQ

Does Bausch Health Companies Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Bausch Health Companies Inc.?

Bausch Health Companies Inc. is classified as a Stock. You can compare it against 5 other assets in the "Related Symbols" list on this page.

Company Profile

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Exchange Ticker
MEX (Mexico) BHCN.MX
FRA (Germany) BVF.F
STU (Germany) BVF.SG
NYQ (United States) BHC
TOR (Canada) BHC.TO
Trades
Dividend History paid per year (EUR)
Historical Dividends
Year Total Dividends
▸2010
0.86 EUR
Nov. 10, 2010 0.8583
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion